Karyopharm Therapeutics Inc. (KPTI)
$0.43-15.69%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- 1.04
- P/E (TTM)
- -0.02
- Short % float
- 40.89%
- Days to cover
- 4.8
- SI change
- -23.0%
- 1W
- -33.85%
- 1M
- -73.13%
- vs SPY 1W
- -33.71%
- vs SPY 1M
- -75.63%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on KPTI?
- LOPJLB’s latest quantitative signal on Karyopharm Therapeutics Inc. (KPTI) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is KPTI in?
- Karyopharm Therapeutics Inc. (KPTI) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Karyopharm Therapeutics Inc. (KPTI) do?
- Karyopharm Therapeutics Inc. is a pharmaceutical company that has already brought products to market, focusing on identifying, advancing, and selling medications designed to disrupt nuclear export pathways. These drugs are primarily aimed at treating cancer and various other illnesses. The company's strategy involves researching, creating, and marketing innovative Selective Inhibitor of Nuclear…